SlateStone Wealth’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
LMFP
FWIA
DC
CAI
ETC
GI
SlateStone Wealth's MDT Position: Q2 2026 in Review
SlateStone Wealth reduced its Medtronic (MDT) stake by 5.2% in Q2 2026, selling an estimated $276K and leaving 62,995 shares worth $4.93M. The position accounts for 0.38% of the portfolio, ranked #67.
SlateStone Wealth first reported a position in MDT in Q4 2019 and has held it in 23 quarters since. The position peaked at $6.03M in Q4 2025. 576 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- SlateStone Wealth held 62,995 shares of Medtronic worth $4.93M as of Q2 2026.
- SlateStone Wealth sold 3,426 Medtronic shares in Q2 2026, an estimated $276K.
- Medtronic made up 0.38% of SlateStone Wealth's portfolio in Q2 2026, its #67 holding.
- SlateStone Wealth first reported a position in Medtronic in Q4 2019 and has held it in 23 quarters since.
- SlateStone Wealth's Medtronic position peaked at $6.03M in Q4 2025.
- 576 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on SlateStone Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.